Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Pirisi

Showing results (191-200 of 236) with videos related to

Pageof 24
Sort By:
Viruses|January 8, 2025
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter?Carlo Smirne, Maria Grazia Crobu, Irene Landi, et al.
Journal of Autoimmunity|March 1, 2026
Evaluation of non-invasive techniques for the diagnosis of pulmonary complications in systemic sclerosis and scleroderma-like overlap syndromes: role of lung ultrasoundMattia Perazzi, Eleonora Croce, Gabriele Macrì, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 22, 2019
HepaDisk - A new quality of life questionnaire for HCV patientsStefano Fagiuoli, Nicola Caporaso, Filomena Morisco, et al.
Biology|January 21, 2023
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma DevelopmentGian Paolo Caviglia, Maria Lorena Abate, Giulia Troshina, et al.
Plos One|October 24, 2014
Individualized treatment of genotype 1 naïve patients: an Italian multicenter field practice experienceAlessandra Mangia, Giovanni Cenderello, Alessandra Orlandini, et al.
Disease Markers|March 4, 2022
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive ProteinManuela Rizzi, Martina Costanzo, Stelvio Tonello, et al.
Journal of Hepatology|September 29, 2016
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinomaDavid J Pinato, Rohini Sharma, Elias Allara, et al.
Frontiers in Immunology|August 7, 2023
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohortManuela Rizzi, Stelvio Tonello, Cristiana Brinno, et al.
Disease Markers|May 9, 2022
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 PatientsStelvio Tonello, Manuela Rizzi, Erica Matino, et al.
Journal of Hepatocellular Carcinoma|November 9, 2023
Mechanisms of Resistance to Immunotherapy in Hepatocellular CarcinomaGiulia Francesca Manfredi, Ciro Celsa, Chloe John, et al.
Pageof 24

Showing results (191-200 of 236) with videos related to

Sort By:
Pageof 24
Viruses|January 8, 2025
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter?Carlo Smirne, Maria Grazia Crobu, Irene Landi, et al.
Journal of Autoimmunity|March 1, 2026
Evaluation of non-invasive techniques for the diagnosis of pulmonary complications in systemic sclerosis and scleroderma-like overlap syndromes: role of lung ultrasoundMattia Perazzi, Eleonora Croce, Gabriele Macrì, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 22, 2019
HepaDisk - A new quality of life questionnaire for HCV patientsStefano Fagiuoli, Nicola Caporaso, Filomena Morisco, et al.
Biology|January 21, 2023
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma DevelopmentGian Paolo Caviglia, Maria Lorena Abate, Giulia Troshina, et al.
Plos One|October 24, 2014
Individualized treatment of genotype 1 naïve patients: an Italian multicenter field practice experienceAlessandra Mangia, Giovanni Cenderello, Alessandra Orlandini, et al.
Disease Markers|March 4, 2022
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive ProteinManuela Rizzi, Martina Costanzo, Stelvio Tonello, et al.
Journal of Hepatology|September 29, 2016
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinomaDavid J Pinato, Rohini Sharma, Elias Allara, et al.
Frontiers in Immunology|August 7, 2023
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohortManuela Rizzi, Stelvio Tonello, Cristiana Brinno, et al.
Disease Markers|May 9, 2022
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 PatientsStelvio Tonello, Manuela Rizzi, Erica Matino, et al.
Journal of Hepatocellular Carcinoma|November 9, 2023
Mechanisms of Resistance to Immunotherapy in Hepatocellular CarcinomaGiulia Francesca Manfredi, Ciro Celsa, Chloe John, et al.
Pageof 24